Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Malignant Neoplasm of Breast Stage IV
Interventions: DRUG: Fulvestrant
Sponsor: Isabel Blancas